IgM levels, which are closely related to the prognosis of bacterial sepsis, and their protective role in bacterial sepsis has been demonstrated repeatedly in previous studies (29–32); however, no difference in IgM levels was found in SARS-CoV-2 sepsis survivors and nonsurvivors in our study. This evidence concerns the gene CD40LG and bacterial infectious disease with sepsis.